Clinical trial

Effects of Cladribine Tablets on the PK of Microgynon®

NCT03745144

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Mapped RxNorm record Cladribine Normalized identity: cladribineView linked drug · Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Placebo Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Microgynon® Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Effects of Cladribine Tablets on the PK of Microgynon®

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2019-01-17

PhasePHASE1

Conditions

Relapsing Multiple Sclerosis (RMS)unresolved

Interventions

CladribineDRUG · verified · RxNorm: cladribine

PlaceboDRUG

Microgynon®DRUG

Sponsors & collaborators

Merck KGaA, Darmstadt, Germanylead sponsor

Mapped research locations

WarsawPoland1 KatowicePoland1 BochumGermany1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03745144 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.